Anyone wishing to study the combined action of GIP, GLP-1, and glucagon within the same molecule cannot avoid a peptidic, injectable approach, since this receptor breadth has so far not been translatable into an oral small-molecule form
However, tirzepatide appears to have an edge: Tirzepatide: In the SURMOUNT-1 trial, participants taking the highest dose (15 mg) of tirzepatide lost an average of 22.5% of their body weight over 72 weeks
Similar content being viewed by others Subjects Introduction Metabolic disorders, including Type 2 Diabetes Mellitus (T2DM) and obesity, pose a serious public health concern both nationally and globally
Plasma total cholesterol decreased ~30% (P 30%
World J Biol Psychiatry
Looking at changes in key parameters in the phase 3 programme with albiglutide, the fall in HbA1c was 0.6%, in LDL cholesterol was 0.6 mmol/L (2 mg/dL), in systolic blood pressure was 0.6 mmHg, and the weight loss was between 1.5 and 2 kg